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Over-activation of primate subgenual cingulate
cortex enhances the cardiovascular, behavioral
and neural responses to threat
Laith Alexander1,2,4,6, Christian M. Wood 1,2,6, Philip L. R. Gaskin 1,2,5, Stephen J. Sawiak2,3, Tim D. Fryer3,
Young T. Hong3, Lauren McIver1,2, Hannah F. Clarke1,2 & Angela C. Roberts 1,2✉
Stress-related disorders such as depression and anxiety are characterized by enhanced
negative emotion and physiological dysfunction. Whilst elevated activity within area 25 of the
subgenual anterior cingulate cortex (sgACC/25) has been implicated in these illnesses, it is
unknown whether this over-activity is causal. By combining targeted intracerebral micro-
infusions with cardiovascular and behavioral monitoring in marmosets, we show that over-
activation of sgACC/25 reduces vagal tone and heart rate variability, alters cortisol dynamics
during stress and heightens reactivity to proximal and distal threat. 18F-FDG PET imaging
shows these changes are accompanied by altered activity within a network of brain regions
including the amygdala, hypothalamus and dorsolateral prefrontal cortex. Ketamine, shown to
have rapid antidepressant effects, fails to reverse elevated arousal to distal threat contrary to
the beneficial effects we have previously demonstrated on over-activation induced reward
blunting, illustrating the symptom-specificity of its actions.
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Identifying the neurobiological basis of enhanced negativeemotion in stress-related disorders such as depression andanxiety is a major challenge in neuroscience and is crucial in
guiding future treatment strategies. Countless correlative human
neuroimaging studies have related dysfunctional activity within
the ventromedial prefrontal cortex (vmPFC) to impairments in
cardiovascular, endocrine and behavioral indices of negative
emotion, but there are two important outstanding issues. First, it
is unknown whether these activity changes are causal, and second,
if causal, whether this region acts to promote or inhibit stress-
related symptoms.
It is critical to recognize that the vmPFC is a large and likely
functionally heterogenous region, variably including caudal sub-
genual anterior cingulate cortex (sgACC, area 25); rostral sgACC
and medial PFC (areas 14, 10, 24); and pregenual regions of the
anterior cingulate (pgACC, area 32)1–5. Consistent with func-
tional heterogeneity, activity within these subzones has been
linked to several opposing manifestations of negative emotion
and its regulation. For example, sgACC comprises a large portion
of the vmPFC and is associated with threat generalization6,7 but
also threat extinction8,9. An overlapping region (including areas
10, 14, and 25) signals stress controllability10,11 and regulates
emotion-generating structures following stress exposure12. Area
10 specifically has been linked to intolerance of uncertainty
during fear extinction13.
A similar portion of the vmPFC is also implicated in the central
regulation of autonomic function, forming part of a central
autonomic network which functions to maintain a constant
internal milieu14–16. Recently, our laboratory implicated sgACC/
25 but not pgACC/32 in the regulation of basal cardiovascular
activity: temporary inactivation of sgACC/25 in marmosets
increased heart rate variability (HRV) by elevating vagal (para-
sympathetic) tone17. The question remains as to whether the
over-activity in sgACC/25 reported in neuroimaging studies of
people with depression and anxiety5,18–20 is causally related to
their cardiovascular and emotional dysfunction, and if so, how?
Studies in non-human primates (NHPs) are essential in
addressing questions of causality since, compared to rodents, the
structural organization of the vmPFC in NHPs is far closer to that
of humans21,22. The differences between rodent and primate are
highlighted by our recent finding that inactivation of marmoset
sgACC/25 and pgACC/32 has opposing functional effects to that
seen following inactivation of their putative rodent anatomical
homologs (infralimbic cortex and prelimbic cortex respectively)17.
Indeed, the wide and persistent translational gap between
advances in preclinical research and a relative failure to develop
more effective treatments for psychiatric disorders is due, in part,
to a lack of understanding of the complex control of negative
affect exerted by the highly evolved primate vmPFC.
Previously, in the domain of reward, we have shown that over-
activity of marmoset sgACC/25 induces anticipatory and moti-
vational aspects of anhedonia-like behavior, and that ketamine—
shown to have rapid antidepressant effects23—can ameliorate
these deficits24. However, what of the effects of sgACC/25 over-
activity in the negative domain? To address this critical question
the present study takes a comprehensive, multi-dimensional
approach in marmosets to determine whether causal links exist
between over-activity in sgACC/25, physiological dysfunction and
enhanced negative reactivity to threat (Fig. 1).
Using targeted intracerebral microinfusions of the excitatory
amino acid transporter-2 (EAAT-2) inhibitor dihydrokainic acid
(DHK) to reduce glutamate re-uptake from synapses, we
first ascertained the impact of sgACC/25 over-activation on
cardiovascular and endocrine (cortisol) dynamics in an emo-
tionally neutral condition. We then assessed the effect of sgACC/
25 over-activation on several indices of affect regulation during
both proximal and distal threat as defined by the predatory
imminence theory, in which threat engages distinct cognitive and
behavioral strategies depending on its closeness in time and
space25,26.
The first test of the regulation of proximal threat involved a
Pavlovian conditioned threat and extinction paradigm with a
rubber snake as an ethologically relevant unconditioned stimulus
(US). This paradigm was used to investigate the effects of sgACC/
25 over-activation on the extinction of a conditioned threat
response, and the subsequent recall of that extinction memory the
next day. The second test focused on the ability of animals to
discriminate between threatening and safety cues during an
aversive Pavlovian discriminative conditioning paradigm. We
utilized positron emission tomography (PET) imaging of the
glucose analog 2-deoxy-2-[18F]fluoro-D-glucose (18F-FDG) dur-
ing this paradigm to determine the circuit-wide changes asso-
ciated with sgACC/25 over-activation. Finally, we looked to
replicate our previous finding of sgACC/25 over-activation
enhancing arousal to distal threat in the form of a human
intruder24. The novel question we addressed here was whether
this effect could be ameliorated by ketamine, in the same way we
had previously demonstrated that ketamine could ameliorate the
blunting of appetitive anticipatory arousal.
Results
An overview of the marmosets used in these experiments is
shown in Table 1 with an experimental timeline in Fig. 1a and
illustrations of three of the main paradigms in Fig. 1b–d. Histo-
logical assessment of cannula placement is shown in Fig. 1e,
together with estimated spread of infusions27. All sgACC/25
infusions were bilateral. In all conditions, cardiovascular mea-
surements were made using wireless telemetric monitoring with
an aortic catheter probe.
sgACC/25 over-activation impacts basal cardiovascular func-
tion by increasing heart rate and reducing heart rate varia-
bility, without affecting blood pressure or cortisol levels. To
determine the effects of sgACC/25 over-activation on basal car-
diovascular function, seven marmosets were assessed in a famil-
iar, affectively neutral environment in the absence of any cues
(Fig. 1b). Over-activation of sgACC/25 with DHK had no effect
on blood pressure (mean arterial pressure [MAP]; Fig. 2a) but
significantly increased heart rate (Fig. 2b, c), reduced HRV
(Fig. 2d) and altered the sympathetic-parasympathetic balance as
measured by an increase in the ratio between the cardiac sym-
pathetic index (CSI) and cardiac vagal index (CVI, Fig. 2e). There
was a shift towards sympathetic predominance, with a significant
decrease in CVI (Fig. 2f) and increase in CSI (Fig. 2g). In three
animals in which salivary cortisol levels were measured, cortisol
levels did not change from before to after the testing session in
both control and over-activation conditions (Fig. 2h).
sgACC/25 over-activation disrupts the extinction of condi-
tioned proximal threat and generally heightens cardiovascular
arousal. To investigate the effects of sgACC/25 over-activation on
the extinction of Pavlovian conditioning to proximal threat, four
marmosets were tested on an adaptation of the classic Pavlovian
conditioned threat and extinction paradigm used in rodents
(Fig. 1c). The sight of a rubber snake (snakes being a predator of
marmosets and ethologically aversive) replaced an aversive foot
shock as the US (as in ref. 17). This was paired with a 15 s tone as
the conditioned stimulus (CS; Supplement Fig. S1). Marmosets
showed a US-induced rise in blood pressure upon each pre-
sentation of the snake (Supplement Fig. S2A), together with
elevated salivary cortisol levels after snake exposure (Supplement
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Fig. 1 Experimental timeline, task overview, and histological assessment of cannula placements. a Experimental timeline. All marmosets (n= 7) were
first habituated to the testing apparatus so the context became affectively neutral, after which sgACC/25 infusions were carried out in this neutral
condition to assess basal cardiovascular changes. Next, marmosets underwent infusions on the conditioned threat and extinction (n= 4) and aversive
Pavlovian discriminative conditioning (n= 7) paradigms (see Table 1 for details). Human intruder (HI) testing (n= 7) was interleaved with aversive
discrimination testing. Finally, four marmosets underwent 18F-FDG PET scanning. b In the neutral condition, no CSs were presented. c In the Pavlovian
conditioned threat and extinction paradigm, habituation occured over the first two days; learning of the CS (auditory cue)-US (rubber snake) association
occurred over the third acquisition day; and on the subsequent extinction and extinction-recall days (days four and five), the cue was presented without the
snake. d In the aversive Pavlovian discriminative conditioning paradigm, marmosets learned to distinguish between a threatening auditory cue (CS+)
predicting aversive white noise and darkness (US+), and a safety auditory cue (CS−) predicting a neutral tone (US−). e Histological assessment of
cannula placement using cresyl-violet staining. No damage was noted in any animals aside from the small area of gliosis used to pinpoint cannula
placement. A schematic diagram, left, shows the cannula placement for all marmosets reported in the manuscript (anteroposterior [AP] extent between
+12.5 and +13.8 mm from interaural line, diagram centered around +13.0mm) together with the estimated spread of infusion in gray (0.5–1.0mm). A
representative cresyl-violet stained histological section is shown right, with the cannulation site indicated by an arrow.
Table 1 Subject involvement in each phase of the study.
Subject Sex Symbol Number of
infusions
Basal
cardiovascular
analysis
Conditioned threat and
extinction
Aversive Pavlovian discriminative
conditioning
Human
intruder testing
Infusion
testing
18F-FDG PET
scanning
1 F ▽ 21 ✓a ✓b ✓c* ✓c*
2 M △ 19 ✓a ✓b ✓c* ✓c*
3 M □ 25 ✓a ✓b ✓c* ✓d ✓c*
4 M ○ 24 ✓a ✓b ✓c* ✓d ✓c*
5 F ▯ 22 ✓a ✓b* ✓c ✓b*
6 M ◇ 16 ✓a ✓b* ✓b*
7 F ⊗ 19 ✓a ✓b* ✓c ✓b*
A tick indicates that the subject took part in that phase of the study, with letters a–d denoting the order of testing.
A star (*) indicates parallel testing phases. See Methods for full explanation of why not all animals were tested in all conditions.
F female, M male.
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Fig. S2B). They also acquired a conditioned vigilant scanning
(VS) response to the CS during the acquisition session; this effect
remained stable across infusion blocks and did not differ between
“to be saline” and “to be over-activation” blocks (Fig. 3a, acqui-
sition). As expected, this response declined across the extinction
session when the rubber snake was no longer presented (Fig. 3a,
extinction, gray line) and showed partial re-instatement and re-
extinction on the extinction recall session (Fig. 3a, extinction
recall, gray line) under the control (saline) condition. A similar
pattern of acquisition, extinction and extinction recall was seen
with respect to conditioned blood pressure (Fig. 3b, gray lines)
except that the conditioned response was not CS specific (Sup-
plement Fig. S2C). Instead, the rise in blood pressure generalized
to the context as indicated by a sustained elevation in blood
pressure following the first US+ presentation (as seen by the step
change in blood pressure in Supplement Fig. S2A).
Over-activation of sgACC/25 prior to the extinction session
elevated both blood pressure and VS responses during extinction
(Fig. 3a, b, extinction, orange lines). However, while the
extinction of VS behavior was blocked following over-activation,
the rate of blood pressure extinction remained the same. Salivary
cortisol samples were acquired pre- and post-extinction: the ratio
of post-extinction to pre-extinction cortisol was significantly
higher following over-activation compared to saline infusions
(Supplement Fig. S3). Therefore, while sgACC/25 over-activation
does not affect cortisol levels in basal conditions, it appears to
potentiate HPA axis activity in threatening contexts. On the
subsequent extinction recall day, during which no infusion took
place, VS behavior remained elevated but extinguished across
repeated CS presentations compared to control conditions
(Fig. 3a, extinction recall, orange line). Blood pressure remained
systematically higher than in control conditions (Fig. 3b,
extinction recall, orange line).
The effect of sgACC/25 over-activation to elevate cardiovas-
cular and behavioral arousal was not confined to CS periods.
When blood pressure values were plotted across the entire
extinction and extinction recall sessions, it was clear there was a
sustained elevation in blood pressure (Fig. 3c, e). This blood
pressure effect was not observed in the affectively neutral
condition, highlighting the dependency on an affectively
negative/threatening context. There was also a tendency for
increased VS during the baseline periods (Fig. 3d, f), again
indicating a generalization effect, although these changes were not
statistically significant.
sgACC/25 over-activation increases arousal when dis-
criminating between threat and safety cues during aversive
Pavlovian discriminative conditioning, and induces metabolic
changes in the amygdala, hypothalamus, and prefrontal cortex.
Having shown generalization effects on the conditioned threat
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Fig. 2 sgACC/25 over-activation shifts the sympathetic-to-parasympathetic balance, increasing heart rate and reducing heart rate variability. Gray=
control, orange= over-activation. Shading and error bars represent SEM. n= 7 except cortisol where n= 3. a sgACC/25 over-activation had no effect on
blood pressure (mean arterial pressure, MAP) measured across the session (two-tailed paired t-test, p= 0.626). b sgACC/25 over-activation significantly
increased heart rate (HR) measured across the session (two-tailed paired t-test, p < 0.001, d= 2.27). c Analysis of second-by-second heart rate
values highlighted a systematic increase across the entire session (linear mixed-model, manipulation × time, F < 1, p= 0.999; main effect of manipulation,
F1,5899= 3448, p < 0.001, d= 2.02). d sgACC/25 over-activation reduced heart rate variability (HRV) as measured by the root mean square differences of
successive R-R intervals (RMSSD; two-tailed paired t-test, p= 0.001, d= 2.20). e Fractionating HRV into cardiac sympathetic (CSI) and cardiac vagal
(CVI) indices revealed sgACC/25 over-activation shifted sympathetic/parasympathetic balance towards sympathetic predominance (two-tailed paired
t-test, p= 0.004, d= 1.69). f sgACC/25 over-activation significantly decreased CVI (two-tailed paired t-test, p= 0.011, d= 1.38) and g significantly
increased CSI (two-tailed paired t-test, p= 0.032, d= 1.07). h Cortisol levels did not change from before to after the habituation session (mean ± SEM
ratio: control 0.937 ± 0.159, over-activation 0.951 ± 0.080) and did not differ between control and over-activation conditions (two-tailed paired t-test, p=
0.960). Source data are provided as a Source Data file.
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and extinction paradigm, we next investigated the effects of over-
activation specifically on marmosets’ ability to discriminate
between threatening and safe cues. This allowed us to determine
the extent and specificity of the generalization effect to proximal
threats. In the aversive Pavlovian discriminative conditioning
paradigm (Fig. 1d), seven marmosets were presented with two
cues: a threatening auditory cue (CS+, 20 s) that predicted a
period of mildly aversive darkness and unpredictable white noise
(US+, 30 s), and a safety cue (CS−, 20s), which predicted a non-
aversive tone (US–, 0.5 s; Supplement Fig. S4). On infusion days,
two safety cues were presented with one threatening cue in the
order CS-1/CS+/CS-2.
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Marmosets successfully acquired CS directed conditioned VS,
blood pressure and heart rate responses together with a robust
blood pressure response to the US+ (Supplement Fig. S5). While
sgACC/25 over-activation did not significantly impact upon
animals’ behavioral or cardiovascular discrimination between the
cues (Fig. 4a, b), it did induce a generalized increase in arousal
indicated by an elevation in VS and blood pressure responses
during the baseline (BL) periods, 20 s before CS onset (Fig. 4c, d).
To determine whether the recovery from a stressor (US+) was
also affected by sgACC/25 over-activation, the 10 s period
following US termination was analyzed. During this period,
blood pressure values remained higher for longer after over-
activation (Fig. 4e). This suggests that recovery from a stressor is
slowed by sgACC/25 over-activation, although this finding is
confounded by the baseline effects of over-activation.
To assess circuit-wide changes induced by sgACC/25 over-
activation during the task, four of the seven marmosets under-
went 18F-FDG PET imaging. Each marmoset had two counter-
balanced scans: one following saline infusion and one following
over-activation using DHK. In all scans, marmosets were injected
with 18F-FDG and received a lengthened version of the aversive
Pavlovian discriminative conditioning session in the test
apparatus (Fig. 5a). They were then anesthetized and scanned.
For the voxel-wise analysis, paired t-tests were performed in a
general linear model with contrasts for increases and reductions
in 18F-FDG uptake (standardized uptake value ration (SUVR)
compared to the cerebellum) following over-activation with DHK
versus saline controls. We had a priori interest in regions with
which sgACC/25 has strong reciprocal connectivity, including
orbitofrontal cortex (OFC), frontopolar cortex, lateral PFC,
medial temporal lobe, and diencephalon28.
In the first demonstration of the brain effects of sgACC/25
over-activation in negatively valenced behavioral settings, ima-
ging showed that over-activation increased 18F-FDG uptake in
sgACC/25 together with increases in the amygdala, hypothalamus
and temporal lobe (Fig. 5b). Lower metabolic activity was found
in dorsolateral prefrontal cortex (dlPFC)/46, central orbitofrontal
cortex (OFC)/13, frontopolar cortex/9 and caudate (Fig. 5c).
These imaging changes were accompanied by elevated behavioral
and cardiovascular arousal during the task (Supplement Fig. S6).
Over-activation induced increases in anxiety-like responses to a
human intruder are not ameliorated by ketamine. To investi-
gate distal threat processing, we assessed the responsivity of seven
marmosets to a human intruder (HI)—a distal threat in the form
of an unfamiliar human, to which marmosets display a range of
behaviors (Fig. 6a). As described in ref. 29, we used exploratory
factor analysis (EFA) to load these behaviors onto a single latent
factor representing anxiety-like responses (Fig. 6b). Over-
activation of sgACC/25 enhanced responsivity of marmosets to
the HI, as evidenced by an increased factor score (Fig. 6c),
replicating a finding previously reported by our laboratory24.
The heightened anxiety-like behavior to the HI following
sgACC/25 over-activation provided us with an opportunity to
compare the efficacy of ketamine in ameliorating this phenotype
with its efficacy in ameliorating an anticipatory anhedonia-like
phenotype induced by the same manipulation reported pre-
viously24. Marmosets were injected with 0.5 mg/kg ketamine i.m.
and were tested 24 h later on the HI paradigm following sgACC/
25 over-activation (Fig. 6a). This timepoint corresponds to one of
the timepoints at which ketamine successfully reversed antici-
patory reward blunting24. However, in the case of the HI test,
ketamine had no effect on anxiety-like behavior—the anxiogenic
effect induced by sgACC/25 over-activation was still observed
(Fig. 6c). Detailed responses of animals across all conditions
reported here are shown in Supplement Table S1.
Discussion
Until now it was unknown whether the altered vmPFC activity
demonstrated in correlative neuroimaging studies of mood and
anxiety disorders could cause dysregulation of negative emotion,
and if so, where the critical locus was located within vmPFC and
the direction of its effects. The findings here directly address these
questions by showing that over-activation of the caudal subgenual
region of primate vmPFC, sgACC/25, reduces basal HRV and
enhances both proximal and distal threat-evoked cardiovascular
and behavioral arousal mirroring the changes observed in stress-
related disorders. We have previously demonstrated the selective
effects of sgACC/25 manipulations compared to adjacent brain
regions17,24, highlighting that this causal link is specific to
sgACC/25.
Fig. 3 sgACC/25 over-activation elevates threat-related arousal during threat extinction and extinction-recall. Gray= control, orange= over-
activation. Shading and error bars represent SEM. Infusions took place prior to extinction sessions, indicated by arrows above figures (a, b). n= 4. a During
acquisition sessions, animals increased their vigilant scanning (VS) response from the pre-snake to post-snake phase in both the “to be saline” and “to-be
overactivation” blocks (two-way repeated measures ANOVA, manipulation × phase, F1,3= 1.4, p= 0.317; main effect of phase, F1,3= 36.5, p= 0.009, η2=
0.777). sgACC/25 over-activation blocked behavioral extinction (two-way repeated measures ANOVA, manipulation × CS pair, F4,12= 3.6, p= 0.039,
η2= 0.087) with significant differences in scanning responses evident during the second (Sidak’s test, p= 0.039, d= 1.86), third (p= 0.007, d= 2.04)
and fifth (p= 0.023, d= 1.05) CS pairs, but not the first (p= 0.974) or fourth (p= 0.0602). These effects persisted to the next day with sgACC/25 over-
activation elevating VS across extinction recall (two-way repeated measures ANOVA, manipulation × CS pair, F4,12= 4.0, p= 0.027, η2= 0.039) evident
across all CS pairs (Sidak’s test, first p < 0.001, d= 2.55; second p < 0.001, d= 1.39; third p < 0.001, d= 1.22; fourth p= 0.003, d= 1.08; fifth p= 0.026,
d= 0.83). b Equally, the blood pressure (MAP) increase during acquisition was not different in the “to be saline” vs. “to be overactivation” blocks (two-way
repeated measures ANOVA, manipulation × phase, F < 1, p= 0.695; main effect of phase, F1,3= 44.5, p= 0.007, η2= 0.503). sgACC/25 over-activation
did not alter the rate of blood pressure extinction (two-way repeated measures ANOVA, manipulation × CS pair, F < 1, p= 0.668; main effect of CS pair,
F4,12= 16.0, p < 0.001, η2= 0.069) but did elevate blood pressure responses across all CS pairs (two-way repeated measures ANOVA, main effect of
manipulation, F1,3= 11.8, p= 0.042, η2= 0.180). Marmosets continued to extinguish their blood pressure responding during extinction recall (two-way
repeated measures ANOVA, main effect of CS pair, F4,12= 4.2, p= 0.023, η2= 0.113) and again there was a systematic elevation in blood pressure
responses following over-activation (two-way repeated measures ANOVA, main effect of infusion, F1,3= 39.1, p= 0.008, η2= 0.562). c Plotting second-
by-second blood pressure values for all four animals during extinction revealed an increase across the entire session, not restricted to CS periods (linear
mixed-model, manipulation × time, F < 1, p= 0.999; main effect of manipulation, F1,5330= 1897, p < 0.001, d= 1.17). d Three out of four animals showed
increased scanning during the baseline periods of the extinction session following over-activation, suggestive of a behavioral generalization response, but
the increase was not significant (two-tailed paired t-test, p= 0.182). e A systematic elevation in blood pressure values was also evident for all four animals
across the extinction recall session (linear mixed-model, manipulation × time, F < 1, p= 0.999; main effect of manipulation, F1,6547= 720, p < 0.001, d=
1.34). f Again, three out of four animals also showed elevated baseline scanning following over-activation in the extinction recall session, but this change
was not significant (two-tailed paired t-test, p= 0.087). Source data are provided as a Source Data file.
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In affectively neutral conditions, sgACC/25 over-activation
significantly increased basal heart rate and reduced HRV, an
effect mediated by a shift in the parasympathetic-to-sympathetic
balance similar to that apparent in mood and anxiety disorders.
The perigenual and subgenual portions of the vmPFC have been
related to vagal reactivity previously. For example, variation in the
high-frequency component of HRV (thought to reflect mainly
parasympathetic tone) is strongly correlated with pg/sgACC
BOLD signal30,31. However, it is important to note that the areas
of activation in such studies typically correspond to areas 10, 24,
and 32—not area 25. We have shown here that there is a causal
relationship between elevated sgACC/25 activity and reduced
parasympathetic tone, consistent with previous findings from our
group with respect to inactivation17.
These results are also consistent with the anatomical con-
nectivity of sgACC/25 identified from tracing studies. Neurons
from primate sgACC/25 project directly to the brainstem but also
indirectly via the hypothalamus and amygdala indicating that
sgACC/25 has dual access to an emotional-visceral motor
system28,32–34. Consistent with this, the 18F-FDG PET imaging in
this study shows effects of sgACC/25 over-activation on both
amygdala and hypothalamic activity. We have also previously
shown links between sgACC/25 over-activity and reduced activity
in the nucleus of the solitary tract24. Given the relationship
between vagal tone and sgACC/25 activity demonstrated here,
one might speculate that vagus nerve stimulation—a treatment
for depression—may exert some of its therapeutic effects through
modulation of sgACC/25. Indeed, chronic stimulation of the
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Fig. 4 Intact discrimination between threat and safety cues, but elevated baseline responding and slowed stress recovery, following sgACC/25 over-
activation. Gray= control, orange= over-activation. Shading and error bars represent SEM. BL indicates baseline (20s pre-CS). n= 7. a sgACC/25 over-
activation did not alter behavioral discrimination between safety (CS-1 and CS-2) cues and a threatening (CS+) cue (two-way repeated measures ANOVA,
manipulation × CS, F < 1, p= 0.647; main effect of CS type, F2,12= 32.3, p < 0.001, η2= 0.619). b There was a trend towards flattening of the blood pressure
(MAP) discrimination between safety cues and a threatening cue following over-activation (two-way repeated measures ANOVA, manipulation × CS,
F2,12= 3.8, p= 0.054; main effect of CS type, F2,12= 19.5, p < 0.001, η2= 0.382). c sgACC/25 over-activation elevated baseline VS (two-way repeated
measures ANOVA, manipulation × CS, F < 1, p= 0.909; main effect of manipulation, F1,6= 8.4, p= 0.027, η2= 0.307). d sgACC/25 over-activation also
elevated baseline blood pressure (two-way repeated measures ANOVA, manipulation × CS, F2,12= 2.5, p= 0.124; main effect of manipulation, F1,6= 22.7,
p= 0.003, η2= 0.062). e Trace showing mean blood pressure responses during the baseline, CS, US and recovery (R) phases of the CS+ trial. The
recovery period was defined as the 10s period following termination of the US+. sgACC/25 over-activation slowed the decline in blood pressure
(measured as a ratio of the blood pressure to the final second of the US+, inset; two-way repeated measures ANOVA, manipulation × time, F9,54= 3.0,
p= 0.005, η2= 0.049). Source data are provided as a Source Data file.
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vagal nerve reduces subgenual prefrontal metabolism with the
earliest changes detectable in sgACC/25, gradually extending
rostrally to encompass vmPFC more broadly (including areas 10/
14) over a 6–12-month-period35 possibly reflecting the normal-
ization of activity in a hyperactive sgACC/25.
Across two different Pavlovian conditioning paradigms of
proximal threat, sgACC/25 over-activation enhanced cardiovas-
cular and behavioral arousal in a manner unrestricted to CS
periods, instead increasing arousal across the entire test session
consistent with generalization to the context. Such effects mirror
the elevated sgACC activity associated with contextual con-
ditioning and during sustained or unpredictable threat in
humans18,19,36. Both discrete and contextual Pavlovian processes
are thought to contribute to anxiety disorders37, but contextual
arousal is particularly relevant to psychopathologies characterized
by sustained or “free-floating” anxiety when there is no clear
threat-eliciting stimulus, such as generalized anxiety disorder.
The generalized elevation in arousal associated with sgACC/25
over-activation may be consistent with the exaggerated responses
to ineffable threat seen in these disorders, but contrasts with the
view that the vmPFC acts to inhibit emotion-generating struc-
tures38–40.
18F-FDG PET imaging in the context of aversive Pavlovian
discriminative conditioning revealed a somewhat different net-
work of brain regions affected by sgACC/25 over-activity to those
previously shown to be affected in the context of appetitive
arousal24. While caution is warranted owing to the relatively
small numbers of subjects inherent in pharmacological
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Fig. 5 Circuit-wide changes associated with sgACC/25 over-activation revealed with 18F-FDG PET imaging. a Four marmosets had a subcutaneous port
implanted into the jugular vein and were trained on a lengthened version of the aversive Pavlovian discriminative conditioning test in preparation for
scanning. Saline (control) and DHK (over-activation) scans were counterbalanced. On the day of the scan (inset), animals were infused with saline or DHK
and immediately injected with 18F-FDG ligand through the port. The conditioning session lasted 30min to increase sensitivity of the ligand to perturbations
in brain activity caused by the paradigm. On the day of scans, this consisted of four CS+/US+ pairings, two CS−/US− pairings and two “probe” trials of a
CS+ alone to limit aversive US exposures. These were presented in a fixed order indicated on the timeline. b Contrast images calculated from standardized
uptake value ratio (SUVR) maps of over-activation—control scans, showing brain regions with increased activity following over-activation. These included
sgACC/25, the amygdala, the ventromedial (VMH) and lateral (LH) hypothalamic nuclei and temporal association area TH (p < 0.005, uncorrected).
c Contrast images calculated from SUVR maps of control—over-activation scans, showing brain regions with reduced activity following over-activation.
These included frontopolar cortex/9, dorsolateral prefrontal cortex (dlPFC)/46, central orbitofrontal cortex (OFC)/13 and the lateral caudate (p < 0.005,
uncorrected). Source data are available from the corresponding author upon request.
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manipulation studies in NHPs, this exploratory analysis showed
increased activity within the amygdala, hypothalamus and tem-
poral lobe—regions known to be connected to sgACC/2528,41.
Activity increases in the former two are consistent with the
potentiation of a behavioral and cardiovascular stress response42
while increases in the latter may be associated with contextual
processing associated with the generalized elevation of arousal to
the context. Reductions in activity were observed in frontopolar
cortex, central OFC/13 and dlPFC/46. Reduced activity within
dlPFC is consistent with neuroimaging findings in people with
major depressive disorder, showing hypoactivity in dorsal PFC
regions coupled with hyperactivity in ventral regions including
sgACC4,43. dlPFC is recruited during the reappraisal of emotions,
and its hypoactivity may thus reflect impaired regulation of
emotion44. Reduction in its activity following sgACC/25 over-
activation observed here could suggest that hyperactivity in more
ventral regions may be causal in the disruption of higher-order
emotion regulation structures, and that dorsal regions may need
to undergo plastic changes over time in order to adapt to pro-
longed hyperactivity in sgACC/25.
In marked contrast to the comparability of these findings to
studies in depressed and anxious humans, they appear in oppo-
sition to those pertaining to the putative rodent homolog—
infralimbic cortex (IL)—during extinction. Electrophysiological
and immunohistochemical evidence suggests that increased
activity within IL correlates with reduced fear during extinction
retrieval45–47. Pharmacological48 and optogenetic49 over-
activation of IL also enhances extinction learning. Rodent stu-
dies, therefore, suggest that increased IL activity is associated with
reduced threat-elicited responding. The results reported here
indicate the opposite in the case of the primate anatomical
homolog: increased activity in marmoset sgACC/25 enhances
threat-elicited responding. This calls into question the hypothesis
that sgACC/25 and IL are functionally analogous and at the very
least encourages a more in-depth investigation into the contextual
variables across marmoset and rodent studies that could be
responsible for such opposing effects.
Given our previous findings that ketamine successfully reverses
sgACC/25 over-activation induced blunting of appetitive antici-
patory arousal24, it was important to determine whether ketamine
could similarly reverse the over-activation induced enhancement of
negative affect. A single i.m. dose of ketamine failed to ameliorate
the heightened anxiety-like behavior in response to a human
intruder. The enhanced responsivity to uncertain threat following
sgACC/25 over-activation replicates previous work in our labora-
tory24 and is consistent with findings in macaques showing that
sgACC/25 activity is related to cortisol responses measured during
intruder exposure50. Its unresponsiveness to ketamine would sug-
gest that there are distinct downstream mechanisms at play
underlying the enhancement in threat processing vs. blunted
reward processing, consistent with the different patterns of network
activity engaged following sgACC/25 activation in response to
reward and threat. While ketamine’s beneficial effects in people
with depression and anhedonia are thought to depend on mod-
ulating sgACC activity51, there are no imaging studies exploring the
brain regions affected by ketamine in anxiety disorders. Comparing
the neurobiological correlates of ketamine’s action in these two
conditions may yet provide further insight into its action.
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Fig. 6 Ketamine does not reverse heightened anxiety-like behavior induced by sgACC/25 over-activation on the Human Intruder (HI) test. Gray=
control, orange= over-activation. Error bars represent SEM. n= 7. a All seven animals had three HI testing sessions. The first two sessions were
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= 1.54). Source data are provided as a Source Data file.
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This work lays the fundamental groundwork for several
exciting future avenues exploring prefrontal contributions to
stress-related disorders. The manipulations described in this
study were acute whereas depression and anxiety are chronic
conditions, so the effects of sustained sgACC/25 over-activity
should be ascertained by using, for example, viral-mediated
technologies. Such techniques could also fractionate the specific
pathways that may underlie the blunted appetitive and heigh-
tened aversive responses induced by over-activation, which can
co-exist in people with depression. Importantly, these techniques
could also be used to identify the nature of the hierarchical
interactions between higher-order prefrontal areas and sgACC/25
in the overall control of reward and threat-related behaviors.
The data presented here causally implicate over-activity in
sgACC/25 in core features of stress-related disorders: both phy-
siological dysfunction and enhanced cardiovascular and beha-
vioral arousal in aversive contexts. While the vmPFC is often
framed as an inhibitory regulator of subcortical emotion-
generating structures, these data specifically implicate sgACC/25
over-activity as promoting a maladaptive stress response. The
lack of efficacy of ketamine in reversing elevations of aversive
arousal contrasts with our previous report of its efficacy in
reversing over-activation induced blunting of reward anticipation.
Altogether, these findings reveal the striking opponency of
sgACC/25 over-activity on threat-elicited responses compared to
reward responses, which parallel the anxiety and anhedonia-
related symptoms of stress-related disorders, and their differential
sensitivity to antidepressant treatment.
Methods
Subjects. Seven marmosets (Callithrix jacchus, three females and four males) bred
on-site at the University of Cambridge Marmoset Breeding Colony were housed in
male/female pairs (males were vasectomized). All were experimentally naive at the
start of testing.
Animals were kept in a 12-h light–dark cycle (lights on at 7 a.m., lights off at 7
p.m.) in a controlled environment of 22 ± 1 °C temperature and 50 ± 1% humidity.
Their cages (2.80 x 1.20 x 0.98 m) contained a nest-box together with a variety of
environmental enrichment aids, including suspended ladders, wooden branches,
ropes, and boxes. Animals had ad libitum access to water and were fed a varied diet
of MP.E1 primate diet (Special Diet Services, Essex, UK), carrot, fruit, rusk, malt
loaf, eggs and bread. All procedures were carried out in accordance with the UK
Animals (Scientific Procedures) Act 1986 and the University of Cambridge Animal
Welfare and Ethical Review Body.
Surgical procedures. All animals underwent three aseptic surgical procedures: one
to implant a telemetric blood pressure monitor into the descending aorta, a second
to implant intracerebral cannulae targeting sgACC/25 and a third to implant a
vascular access port for administration of 18F-FDG. Animals had 7–10 days of
recovery following all surgical procedures.
Telemetry surgery. Marmosets were pre-medicated with ketamine (Ketavet; 10mg/
0.1ml i.m. injection; Henry Schein, Melville, NY) before receiving the analgesic
Carprofen (1.5mg/0.03ml s.c.; Pfizer, Kent, UK). They were intubated and main-
tained on 2.0–2.5% isoflurane in 0.3 l/min O2. Animals were monitored throughout
using pulse-oximetry and capnography (Microcap Handheld Capnograph, Oridion
Capnography Inc., MA, USA) as well as a rectal thermometer measuring core body
temperature (TES-1319 K-type digital thermometer, TES Electrical Electronic Corp,
Taipei, Taiwan). The descending aorta was visualized within the abdominal cavity and
the probe catheter of a telemetric blood pressure transmitter (HDS-10, Data Sciences
International, USA) was implanted into the aorta just above the aortic bifurcation.
Blood flow was occluded for no more than 3min. The probe was sutured in place
within the abdomen. All monkeys received meloxicam (0.15mg/0.1ml p.o.; Boeh-
ringer Ingelheim) postoperatively for three days in addition to prophylactic antibiotic
treatment with amoxicillin and clavulanic acid (Synulox; 50mg/ml solution, Pfizer,
Kent, UK) one day before and for six days after surgery.
Cannulation surgery. Animals were anesthetized as before and placed into a
stereotaxic frame modified for the marmoset (David Kopf, Tujunga, CA, USA).
Cannulae (Plastics One, Roanoke, VA, USA) were implanted into sgACC/25 (26-
gauge double cannulae, 7.0 mm protrusion from the base of the guide, 1.0 to 1.4
mm apart, anteroposterior [AP]+ 12.5–13.8, lateromedial [LM] ± 0.7) adjusted in-
situ according to cortical depth52. Postoperatively, animals received the analgesic
meloxicam as above. The cannulae and mount were cleaned weekly (and caps and
cannula blockers changed) to ensure the cannulae were patent and the site
remained free from infection.
Port implantation surgery. A vascular access port (Solomon Scientific, Skokie, IL,
USA) was implanted into seven animals to allow swift subcutaneous injection of
18F-FDG. Animals were anesthetized and placed on to the surgical table in a prone
position. An incision was made below the shoulder-blades perpendicular to the axis
of the spine where the port would be placed, and a second incision was made on
the neck to expose the jugular vein. A catheter attached to the port was threaded
under the skin from the back towards the vein. The port was placed in a skin
pocket created by the first incision. A small incision was made in the jugular vein to
insert the open end of the catheter in the direction of the heart. The catheter was
glued to the vein with Vetbond (3M Animal Care Products, St. Paul, MN, USA)
and the incisions on the back and neck were sutured. All animals received
meloxicam and amoxicillin/clavulanic acid perioperatively as above.
Behavioral testing apparatus and paradigms. In all paradigms except for the
human intruder test, animals were trained to enter a transparent Perspex carry-box
(240 × 230 × 200 mm) in which they were transported to the behavioral testing
apparatus. The carry-box had two circular windows (diameter 30 mm) on opposite
sides. The Perspex carry-box was placed inside the test chamber, and the marmoset
remained inside this box during testing.
For practical reasons regarding constraints on the testing apparatus, the behavioral
order of the tests was not counterbalanced: all animals progressed from testing in the
neutral condition, to the conditioned threat and extinction paradigm, to the aversive
Pavlovian discrimination test with the human intruder test done in parallel. For each
behavioral paradigm, a within-subject control infusion was always carried out and in
all cases during control infusions the animals showed the appropriate behavioral and
cardiovascular responses to be expected in each paradigm.
Neutral condition. In the neutral condition, marmosets were placed inside a
bespoke sound-attenuated testing chamber with the houselight turned on. Initial
sessions were 5 min long, with the length extended to a maximum of 20 min over a
period of 5–7 days. The animals were judged to have habituated when heart rate
reached a stable level across two days (mean heart rate within ± 10%) and when
animals showed a relaxed, still and non-vigilant posture. The total number of
habituation sessions depended on the individual animal’s rate of acclimatization to
the apparatus (mean ± SEM number of sessions: 25 ± 6).
Pavlovian conditioned threat and extinction test. Pavlovian conditioned threat
and extinction testing occurred inside a bespoke testing chamber. One wall of the
chamber consisted of a pane of switchable SmartGlass (SmartGlass International®,
Dublin, Ireland). The opacity of the SmartGlass pane is altered when voltage is
applied, changing from opaque to transparent. When the SmartGlass is transpar-
ent, it reveals an additional section of the testing chamber. A rubber snake (US+)
was placed in this chamber for specific trials of the acquisition session only.
A single block of the conditioned threat and extinction paradigm consisted of
five sessions, run over five consecutive days (Supplement Fig. S1):
● Sessions 1–2 (habituation)—Animals were habituated to 12 trials (inter-trial
interval (ITI) 110–130 s) of the SmartGlass illuminating for 5 s to show the
empty additional chamber (unconditioned stimulus -; US-).
● Session 3 (acquisition)—Conditioned stimuli (CS) were introduced as 15 s, 70
dB auditory cues. Each of the nine trials consisted of a 15 s CS and a 5 s US
(ITI 160–180 s). CSs persisted for the 5 s of the US to co-terminate with the
US. The first three CS presentations were paired with the US-. The final six
CSs were paired with the US+ (pane turning transparent to reveal the rubber
snake in the additional chamber).
● Session 4 (extinction)—Each of the ten trials consisted of the 15 s CS followed
by the US- (ITI 60–80 s). Control or over-activation infusions were carried out
immediately prior to the extinction session to determine the effects of sgACC/
25 activation on the expression and extinction of conditioned threat.
● Session 5 (extinction recall)—Ten CS/US- trials (ITI 70–110 s), identical to
extinction, were presented to test for recall of threat extinction.
Three blocks of five sessions were repeated for each subject with a 1-week gap
between blocks. These included two saline control blocks and one over-activation
block. The first block (always saline) was used as a baseline block—the habituation
sessions of this block were not comparable to the second and third blocks because
the animal had never experienced the aversive snake in the chamber. The second
and third blocks were used in data analysis, and control and over-activation
manipulations were counterbalanced within these blocks. To minimize threat
generalization between blocks, distinct patterned wall panels were introduced to
vary the context and different auditory cues were used as CSs.
Four out of seven marmosets were tested on the Pavlovian conditioned threat
and extinction test; three moved straight onto the aversive Pavlovian discriminative
conditioning test following the neutral condition. Of these three, two marmosets’
testing schedules were expedited due to SARS-CoV-2 while one marmoset failed to
show sufficient reactivity to the snake US.
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Aversive Pavlovian discriminative conditioning test and PET scanning. During
the aversive Pavlovian discriminative conditioning test, seven marmosets were first
exposed to two novel auditory cues (20 s) and the blood pressure response was
measured. The cues were then counterbalanced such that the cue producing the
smallest arousal response became the CS+ and the cue producing the largest
arousal response became the CS−. The animals were then trained on an aversive
Pavlovian discrimination paradigm (Supplement Fig. S4): the CS+ was associated
with an aversive US+ consisting of 30 s of darkness, with 10 s of 85 dB white noise
pseudo-randomly presented either in the first, second, or third 10 s of the darkness.
The CS− was associated with a 0.5 s 80 dB neutral 2 kHz tone (US-). CSs co-
terminated with their respective USs. ITIs were pseudo-randomly varied between
100–160 s. Each session consisted of two to four trials with no more than one CS
+/US+ trial in a single session. Infusions were always conducted on sessions with a
trial structure of CS−/CS+/CS−.
Seven marmosets were implanted with a subcutaneous port for PET scanning,
but only four were scanned owing to one telemetry probe failure, one port blockage
and one marmoset’s scans halted due to SARS-CoV-2. The four marmosets
undergoing 18F-FDG PET scanning were tested on a lengthened version of the
aversive Pavlovian discrimination test. The length of the session was increased
from 500 s to 1800 s to facilitate perturbation of cerebral 18F-FDG uptake by the
behavioral paradigm. Habituation to these extended testing sessions took place
over ten sessions using the same trial structure as above except with lengthened
ITIs (330–440 s). During training, marmosets were also habituated to all handling
procedures involved on a scan day, including mock injections and infusions but
excluding anesthesia induction. Testing on this lengthened aversive discrimination
test took place every day up until the final scan (except on recovery days following
port implantation surgery or scanning).
The behavioral test on PET scan days was a unique version of the lengthened
conditioning test, consisting of three trial types during the 30-min session: two CS
−/US- trials, four CS+/US+ trials and two probe trials. The latter consisted of the
standard 20 s CS+ but no US+, to limit aversive exposures in one testing session.
The order of CS presentations is detailed in Fig. 5a, with ITIs of 130–180 s.
Human intruder (HI) test. The HI test was carried out in the marmosets’ home
cage. During testing sessions, animals were divided in the top right quadrant of the
cage away from their cage mate. After 8 min of habituation to separation, an
unfamiliar intruder entered the room. The intruder wore different latex masks to
disguise their face. The intruder stood 40 cm from the front of the cage and
maintained eye contact with the marmoset for 2 min. Behaviors were recorded
using a video camera (GoPro 5, USA) and microphone (Sennheiser MKE 400,
Germany). Following intrusion, animals were recorded for a further 5 min. The
order of latex masks was counterbalanced and there was an interval of at least
1 week between each session.
Drug treatments. For all sterile drug treatments, marmosets were held gently by
an assistant familiar to the animal while the researcher administered the drug. For
central infusions, the caps and cannula blockers were removed from the guide, and
the site was cleaned with 70% isopropyl alcohol. A sterile injector (Plastics
One, Roanoke, VA, USA) connected to a 2 μl gas tight syringe in a syringe pump
was inserted into the guide. The length of the injector was determined by cortical
depth and the placement of the guide cannulae during surgery. Bilateral infusions
were carried out over 2 min at a rate of 0.5 μl/min, with the injector left in place for
a further minute to allow the drug to diffuse before injector removal. Sterile can-
nula blockers and caps were replaced, and the marmoset was returned to its cage
for 10 min. For intramuscular injections of ketamine, the injection site located on
the lateral thigh was cleaned with alcohol and injected with 0.5 mg/kg of ketamine
or an equal volume of saline vehicle before testing. See Table S2 for a summary of
timings and doses of the drugs used in this manuscript.
PET imaging. Each marmoset undergoing PET scanning received two 18F-FDG
PET scans with a microPET Focus-220 scanner (Concorde Microsystems, Knox-
ville, TN, USA) with the first scan ~2 weeks after port implant surgery and an
interval between scans of ~2 weeks. On the day of a scan, animals did not receive
breakfast to lower blood glucose concentration and hence increase the transport of
18F-FDG into brain tissue, thereby increasing the cerebral 18F-FDG signal to noise
ratio. The marmoset received an infusion of either saline vehicle or DHK 10 min
prior to a bolus injection of ~70MBq of 18F-FDG administered subcutaneously via
the vascular access port. They were then taken to the test apparatus, and after the
behavioral paradigm described above, the marmoset was anesthetized. The mar-
moset was then placed on a heat-pad on the scanner bed and attached to mon-
itoring equipment. Heart rates, SpO2 and respiratory rates were monitored
continuously. The bed of the scanner was positioned to locate the brain in the
center of the PET scanner field-of-view, where both sensitivity and resolution are
optimal. For consistency, PET data acquisition started 70 min after the 18F-FDG
injection and lasted for 45 min. The energy and coincidence timing windows used
were 350–650 keV and 6 ns, respectively.
The list mode PET data were histogrammed into 9 × 5 min four-dimensional
sinograms and then reconstructed using Fourier rebinning (FORE53), followed by
the two-dimensional ordered subsets expectation maximization (OSEM) algorithm
installed on the scanner (6 iterations, 16 subsets). As post-injection transmission
scanning was not feasible, attenuation correction used a mean non-attenuation
corrected 18F-FDG image to determine a body outline, within which a uniform
attenuation coefficient (0.096 cm−1) was ascribed. This was combined with a
standard attenuation map of the carbon fiber bed determined from transmission
scanning. The combined attenuation map was forward projected using software
installed on the scanner to produce an attenuation correction factor sinogram, and
image reconstruction was repeated with attenuation correction applied.
Corrections were also applied for random coincidences, dead-time, normalization,
scatter, sensitivity and decay.
Salivary cortisol sampling. Salivary cortisol samples were collected in the affec-
tively neutral condition (to measure basal cortisol levels) and in the acquisition and
extinction sessions of the Pavlovian conditioned threat and extinction test (to
measure cortisol dynamics during aversive conditions). A salivary sample of cor-
tisol was taken during the infusion as a “pre” sample before the testing session, with
a second “post” sample taken after testing. Salivary samples were taken by placing a
sterile cotton bud into the marmoset’s mouth and rotating it for 5–15 s to absorb
sufficient saliva. Samples were then placed in sterile tubes and stored in a −20 °C
freezer until processing. The samples were analyzed externally by immunoassay at
the Core Biochemical Assay Laboratory (CBAL) within Addenbrookes’ Hospital
(Cambridge, UK). Salivary cortisol samples were taken at the same time of day for
all animals (~11 and 11:30am) to control for cortisol’s circadian rhythm54. In the
neutral condition, four marmosets had cortisol levels measured but one sample had
insufficient saliva, resulting in a sample size of three (Fig. 2h). In the conditioned
threat and extinction paradigm, all four marmosets had salivary cortisol mea-
surements during acquisition and extinction.
Post-mortem histological processing. Animals were pre-medicated with keta-
mine hydrochloride before being euthanized with sodium pentobarbital (20 mg/1
ml; Merial Animal Health, Essex, UK). Animals were then perfused transcardially
with 300 ml 0.1 M PBS, followed by 300 ml of 4% paraformaldehyde fixative
solution over ~15 min. The brain was removed and left in the 4% paraformalde-
hyde fixative solution overnight before being transferred to 0.01M PBS-azide
solution for at least 48 h. Finally, the brains were transferred to 30% sucrose
solution for at least 48 h for cryoprotection. Brains were then sectioned on a
freezing microtome (coronal sections of 40–60 µm thickness), mounted on slides
and stained with cresyl-violet. The sections were viewed under a light microscope
(Leitz DMRD, Leica Microsystems, Germany). The cannula locations for each
animal were schematized onto drawings of standard marmoset brain coronal
sections (Fig. 1e).
Data acquisition and statistical analysis. For analysis, all data were inputted into
GraphPad Prism 8 (GraphPad Software, La Jolla, CA, USA), IBM SPSS Statistics
v25.0 for Macintosh (IBM, USA) and Microsoft Excel v16.37 for Macintosh
(Microsoft, USA). Significance was set at α= 0.05 in all cases. In the case of all
analysis of variances (ANOVAs), multiple comparisons were calculated using
Sidak’s multiple comparisons test. Effect sizes are presented as Cohen’s d for t-tests,
post-hoc tests and linear models, or η2 for ANOVAs. * indicates p < 0.05,
** indicates p < 0.01 and *** indicates p < 0.001 in all figures.
Telemetry data collection and preliminary analysis: Blood pressure data were
continuously transmitted by the implanted telemetry probe to a receiver for offline
analysis using Spike2 (Version 8.11a, CED, Cambridge, UK). Any outliers and
recording failures in the data were removed (values above 200 mmHg or below 0
mmHg, or other abnormal spikes). Data collection was reliable overall, but data
gaps of less than 0.4 s were replaced by cubic spline interpolation and gaps of more
than 0.4 s were treated as missing values. Systolic blood pressure (sBP) events were
extracted as local maxima from each cardiac cycle, and diastolic blood pressure
(dBP) events extracted as local minima. The heart rate was calculated using the
time interval between adjacent maxima. MAP was calculated from adjacent systolic
and diastolic values using the formula MAP= dBP + 1/3(sBP – dBP).
Neutral condition: In the neutral condition, blood pressure, heart rate and heart
rate variability (HRV) data were collected. For infusion sessions, data were
analyzed over minutes 1–10 where all animals appeared calm from behavioral and
cardiovascular readouts. The 0th minute was excluded to allow time for
acclimatization to the apparatus after transport. The main cardiovascular measures
were blood pressure, heart rate and HRV. HRV was quantified by the root mean
square differences of successive R-R intervals (RMSSD). Indices of sympathetic and
parasympathetic activity, termed the cardiac sympathetic index (CSI) and cardiac
vagal index (CVI), were also calculated as described in ref. 55.
sgACC/25 over-activation was compared to infusions of saline control on
individual cardiovascular measures using two-tailed paired t-tests. Second-by-
second heart rate values were compared using a linear mixed-model with time (in
one-second bins) and manipulation (control, over-activation) as factors.
For all subsequent tests, blood pressure was used as the principal cardiovascular
measure for two reasons: first, in both Pavlovian conditioning tests, blood pressure
conditioning was more consistent compared to heart rate. Second, blood pressure
was unaffected by sgACC/25 over-activation in the affectively neutral condition,
whereas any changes in heart rate values would be confounded by a baseline
NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-020-19167-0 ARTICLE
NATURE COMMUNICATIONS |         (2020) 11:5386 | https://doi.org/10.1038/s41467-020-19167-0 | www.nature.com/naturecommunications 11
cardiovascular effect. The only case where heart rate values were used was in the
PET conditioning paradigm, where responses were more consistent than blood
pressure.
Pavlovian conditioned threat and extinction test: Behavior during CS periods
was scored offline from video recordings of the session. The behavior scored was
vigilant scanning (VS)—attentive scanning of the surroundings accompanied by a
tense body posture17,56,57. VS measures were averaged across CS pairs (as described
in ref. 58). CS directed VS (VSCS period –VSbaseline, where baseline is 15 s pre-CS)
was also calculated, which did show evidence of CS-specific learning (Supplement
Fig. S2C). However, for consistency with cardiovascular measures (see below),
absolute VS values were used for analysis.
Mean blood pressure values were calculated and averaged in CS pairs as above.
Blood pressure responses were normalized (using a difference measure) to the mean
blood pressure response across the two habituation sessions within the block
(accounting for arousal to the context and individual differences in absolute blood
pressure). CS directed blood pressure responses were also calculated and averaged
across CS pairs, but consistent CS directed blood pressure responses were not evident
(Supplement Fig. S2D) so absolute blood pressure values were used for analysis.
To determine if there was any difference in acquisition profiles during the “to be
control” and “to be over-activation” blocks, the absolute blood pressure and
absolute VS values of the final pre-acquisition CS pair were compared to the final
post-acquisition CS pair across both blocks using a two-way repeated measures
ANOVA of the form M 2 × P 2: M is a factor with two levels (manipulation) and P
is a factor with two levels (CS pair; pre- vs. post-acquisition). “Post”:“pre” salivary
cortisol ratios were also calculated for each acquisition block (four subjects, two
blocks each for a total of eight blocks). These ratios were compared to a
hypothetical value of 1.0 (no change) using a one-sample t-test, to determine if
acquisition significantly elevated salivary cortisol.
Absolute VS and blood pressure values during the CS pairs of the extinction and
extinction recall phases were analyzed using separate two-way repeated measures
ANOVAs of the form M2 × P5, where M is a factor with two levels (manipulation)
and P is a factor with five levels (CS pair). Further analysis sought to determine
whether there was a generalized effect of sgACC/25 over-activation on blood
pressure or VS values during extinction/extinction recall sessions. For blood
pressure, this was done by comparing blood pressure profiles across the entire
extinction/extinction recall session (excluding the first minute) using a linear
mixed-model with time (in one-second bins) and manipulation (control/over-
activation) as factors. For VS, this was done by measuring baseline (15 s pre-CS) VS
values across extinction/extinction recall sessions and comparing values between
control and over-activation conditions using a two-tailed paired t-test.
Aversive Pavlovian discriminative conditioning test: The behavior scored was
VS during the CS and baseline periods, and CS directed VS values were calculated
as CS minus baseline as above. The cardiovascular readouts were mean blood
pressure values during the 20 s baseline, 20 s CS and 30 s US+ periods. Both CS
directed and US directed (MAPUS period –MAPCS period) blood pressure responses
were calculated. Unlike the conditioned threat and extinction test, CS directed
conditioning was evident for both VS and blood pressure in this paradigm and
these measures were used in analysis. The 10 s period following termination of the
US+ was defined as the recovery period—this period is of a priori interest as
impaired stress recovery is a key feature of psychiatric disorders59.
To illustrate successful discrimination between CS+ and CS−, a one-way
repeated measures ANOVA was carried out comparing cardiovascular and
behavioral responses to each trial on the CS−/CS+/CS− session immediately prior
to infusions. To demonstrate a response to the US+, US directed blood pressure
responses were compared to a hypothetical value of 0 (no change compared to CS
period) using a one-sample t-test.
For drug manipulations, it was first determined if there were any differences in
CS directed VS and blood pressure responses using a two-way repeated measures
ANOVA of the form M2 × C3, where M is a factor with two levels (manipulation)
and C is a factor with three levels (CS type: CS-1, CS+ or CS-2). Further analysis
sought to determine whether there was a generalized effect of sgACC/25 over-
activation on absolute VS or blood pressure values during the baseline period.
Absolute VS and blood pressure values were compared across infusion type using
separate two-way repeated measures ANOVAs of the form M2 × B3 where M is a
factor with two levels (manipulation type) and B is a factor with three levels
(baseline type: first, second, or third).
During the 10 s recovery period after the US+, ratios were calculated comparing
the blood pressure value in each second to the blood pressure value in the final
second of the US+ period. Ratio values for control and over-activation conditions
were compared using a two-way repeated measures ANOVA of the form M2 × T10
where M is a factor with two levels (manipulation type) and T is a factor with ten
levels (ten 1 s time bins).
For the modified discriminative conditioning for PET scanning, cardiovascular,
and behavioral variables were analyzed across CS, US, and baseline periods for all
trials similar to the standard aversive discrimination test. Mean CS directed data
were analyzed using a two-way repeated measures ANOVA of the form M2 × C3,
where M is a factor with two levels (manipulation type) and C is a factor with three
levels (CS type: CS−, CS+ and probe).
Human intruder (HI) test: A behavioral analysis program (JWatcher v1.0,
UCLA and Macquarie University) was used to score behavior during the intruder
phase. The measures scored were: time spent at the front of the cage (TSAF), time
spent at the back of the cage (TSAB), average height, average depth, bobbing (rapid
side-to-side body movements), jumps, locomotion and vocalizations (egg calls, tsik
call, tsik egg calls, and tse egg calls). Using exploratory factor analysis (EFA) with a
principal axis factoring extraction method, the behaviors were loaded onto a single
latent factor representing anxiety-like behavior (with weightings shown in Fig. 5b;
see ref. 29 for detailed description). Once the EFA-derived anxiety scores were
calculated for each HI session, a one-way repeated measures ANOVA was carried
out to compare the effects of control, over-activation and [over-activation+
ketamine] manipulations on anxiety scores.
The effects of ketamine were only investigated on the HI test owing to
limitations on the number of infusions each animal could receive and timing
constraints on the overall duration of the study.
PET scanning: Magnetic resonance (MR) imaging of the animals was not
possible due to the cannulae implanted in the brain, preventing the use of MR-
based spatial normalization. Instead, first, the mean 18F-FDG PET image of each
scan was manually, rigidly registered to an 18F-FDG PET brain template produced
from another 18F-FDG PET study in the colony that included MR imaging. The
18F-FDG PET brain template was constructed by averaging n= 21 18F-FDG PET
images transformed to template space using registration transformations obtained
by warping MR images (co-registered to the 18F-FDG PET images) to an MR
template. Second, for each subject, the two 18F-FDG PET scans rigidly registered to
the 18F-FDG PET template were averaged, the resultant image was non-rigidly
registered (affine and non-linear) to the 18F-FDG PET template using ANTS60,
and this transformation was applied to each of the three rigidly registered 18F-FDG
PET scans. Use of a single spatial normalization transformation per subject rather
than per 18F-FDG PET scan was adopted after it was found— using the n= 21
18F-FDG PET scans with MR—that this approach provided region of interest
(ROI) PET values with a higher correlation to those obtained using MR-based
spatial normalization (R2= 0.89 vs. R2= 0.87).
For each scan, an SUVR map was created for voxel-wise analysis by dividing the
mean PET image by a cerebellum ROI value. Normalization by the cerebellum signal
was designed to minimize the confounding influence of inter-scan differences in
tracer availability; plasma glucose concentration; the effect of anesthesia on cerebral
blood flow and metabolism; and basal cerebral glucose metabolism.
SPM8 (Wellcome Trust Institute for Neurology, UCL, UK) was used for voxel-
wise analysis. A general linear model was configured with covariates for subject and
condition (saline control vs. over-activation) and changes in activity were tested
with Student’s t-test at each voxel. Prior to estimating the model, images were
smoothed with a filter size of 1 mm3 using a locally adapted Gaussian kernel to
include only those voxels inside a brain mask. With the low numbers of subjects
inherent in invasive primate studies, it is difficult for findings to survive
conservative corrections for multiple comparisons. To provide an exploratory
analysis with some mitigation against type I errors, an adjusted uncorrected
threshold of p < 0.005 was used in combination with a small extent threshold of five
voxels to remove implausible clusters from the statistical maps.
Reporting summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.
Data availability
Source data are provided with this paper using Mendeley Data (https://doi.org/10.17632/
tvxf6f9gj6.1). Raw neuroimaging data are available from the corresponding author upon
request.
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